[1]National Institutes for Food and Drug Control;
Beijing 100050;
China;
[1]National Institutes for Food and Drug Control;
Beijing 100050;
China;
[1]National Institutes for Food and Drug Control;
Beijing 100050;
China;
[1]National Institutes for Food and Drug Control;
Beijing 100050;
China;
Chimeric antigen receptor T cells; Quality control; Nonclinical research; Safety; Efficacy; Clinical trials; Cancer immunotherapy;